Safety Study of Adjuvant Gemcitabine Started One Week After Laparoscopic Distal Pancreatectomy for Adenocarcinoma

NCT01045941 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The study was never initiated

Conditions

Pancreatic Neoplasms

Interventions

DRUG: Gemcitabine/Gemzar
PROCEDURE: Laparoscopic Distal pancreatectomy

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins